GOLDBERG LI, MCDONALD RH Jr, ZIMMERMAN AM. SODIUM DIURESIS PRODUCED BY DOPAMINE IN PATIENTS WITH CONGESTIVE HEART FAILURE. N Engl J Med. 1963 Nov 14;269:1060-4. doi: 10.1056/NEJM196311142692003. PMID: 14085064.
https://doi.org/10.1056/nejm196311142692003
Holzer J, Karliner JS, O’Rourke RA, Pitt W, Ross J Jr. Effectiveness of dopamine in patients with cardiogenic shock. Am J Cardiol. 1973 Jul;32(1):79-84. doi: 10.1016/s0002-9149(73)80088-8. PMID: 4713114.
https://www.ajconline.org/article/S0002-9149(73)80088-8/pdf
Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000 Dec 23-30;356(9248):2139-43. doi: 10.1016/s0140-6736(00)03495-4. PMID: 11191541.
https://doi.org/10.1016/s0140-6736(00)03495-4
Galley HF. Renal-dose dopamine: will the message now get through? Lancet. 2000 Dec 23-30;356(9248):2112-3. doi: 10.1016/S0140-6736(00)03484-X. Erratum in: Lancet 2001 Mar 17;357(9259):890. PMID: 11191531.
https://doi.org/10.1016/s0140-6736(00)03484-x
Romano G, Ferraccioli G. Usefulness of dopamine treatment in non-oliguric renal failure. Lancet. 2001 Mar 24;357(9260):960. doi: 10.1016/S0140-6736(05)71662-7. PMID: 11289376.
https://doi.org/10.1016/s0140-6736(05)71662-7
Maleck WH, Piper SN, Koetter KP. Use of dopamine in acute renal failure. Crit Care Med. 2002 Aug;30(8):1934-6. doi: 10.1097/00003246-200208000-00062. PMID: 12163835.
https://doi.org/10.1097/00003246-200208000-00062
Kellum JA, M Decker J. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med. 2001 Aug;29(8):1526-31. doi: 10.1097/00003246-200108000-00005. PMID: 11505120.
https://doi.org/10.1097/00003246-200108000-00005
Manson DK, Dzierba AL, Seitz KM, Brodie D. Running from a Bear: How We Teach Vasopressors, Adrenoreceptors, and Shock. ATS Sch. 2023 Feb 13;4(2):216-229. doi: 10.34197/ats-scholar.2021-0132HT. PMID: 37533537; PMCID: PMC10391691.
https://doi.org/10.34197/ats-scholar.2021-0132HT
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391691/pdf/ats-scholar.2021-0132HT.pdf
Joannidis M, Druml W, Forni LG, Groeneveld ABJ, Honore PM, Hoste E, Ostermann M, Oudemans-van Straaten HM, Schetz M. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med. 2017 Jun;43(6):730-749. doi: 10.1007/s00134-017-4832-y. Epub 2017 Jun 2. PMID: 28577069; PMCID: PMC5487598.
https://doi.org/10.1007/s00134-017-4832-y
https://link.springer.com/content/pdf/10.1007/s00134-017-4832-y.pdf?pdf=button
Marik PE. Low-dose dopamine: a systematic review. Intensive Care Med. 2002 Jul;28(7):877-83. doi: 10.1007/s00134-002-1346-y. Epub 2002 May 31. PMID: 12122525.
https://doi.org/10.1007/s00134-002-1346-y
Holmes CL, Walley KR. Bad medicine: low-dose dopamine in the ICU. Chest. 2003 Apr;123(4):1266-75. doi: 10.1378/chest.123.4.1266. PMID: 12684320.
https://doi.org/10.1378/chest.123.4.1266
not free but I have it
Debaveye YA, Van den Berghe GH. Is there still a place for dopamine in the modern intensive care unit? Anesth Analg. 2004 Feb;98(2):461-468. doi: 10.1213/01.ANE.0000096188.35789.37. PMID: 14742388.
https://doi.org/10.1213/01.ane.0000096188.35789.37 and full free pdf
Venkataraman R. Can we prevent acute kidney injury? Crit Care Med. 2008 Apr;36(4 Suppl):S166-71. doi: 10.1097/CCM.0b013e318168c74a. PMID: 18382189.
https://doi.org/10.1097/ccm.0b013e318168c74a
Sakr Y, Reinhart K, Vincent JL, Sprung CL, Moreno R, Ranieri VM, De Backer D, Payen D. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med. 2006 Mar;34(3):589-97. doi: 10.1097/01.CCM.0000201896.45809.E3. PMID: 16505643.
https://doi.org/10.1097/01.ccm.0000201896.45809.e3
De Backer D, Aldecoa C, Njimi H, Vincent JL. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*. Crit Care Med. 2012 Mar;40(3):725-30. doi: 10.1097/CCM.0b013e31823778ee. PMID: 22036860.
https://doi.org/10.1097/ccm.0b013e31823778ee
Avni T, Lador A, Lev S, Leibovici L, Paul M, Grossman A. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis. PLoS One. 2015 Aug 3;10(8):e0129305. doi: 10.1371/journal.pone.0129305. PMID: 26237037; PMCID: PMC4523170.
https://doi.org/10.1371/journal.pone.0129305
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0129305&type=printable
Marinosci GZ, De Robertis E, De Benedictis G, Piazza O. Dopamine Use in Intensive Care: Are We Ready to Turn it Down? Transl Med UniSa. 2012 Oct 11;4:90-4. PMID: 23905068; PMCID: PMC3728808.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728808/pdf/tm-04-90.pdf
Annane D. Physicians no longer should consider dopamine for septic shock!*. Crit Care Med. 2012 Mar;40(3):981. doi: 10.1097/CCM.0b013e31823d779b. PMID: 22343841.
https://doi.org/10.1097/ccm.0b013e31823d779b
van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, Menon V, Ohman EM, Sweitzer NK, Thiele H, Washam JB, Cohen MG; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Mission: Lifeline. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation. 2017 Oct 17;136(16):e232-e268. doi: 10.1161/CIR.0000000000000525. Epub 2017 Sep 18. PMID: 28923988.
https://doi.org/10.1161/cir.0000000000000525
Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O’Meara E, Tang WH, Starling RC, Butler J, Deswal A, Felker GM, O’Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Mann DL, Dávila-Román VG, McNulty SE, Borlaug BA, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM; NHLBI Heart Failure Clinical Research Network. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013 Dec 18;310(23):2533-43. doi: 10.1001/jama.2013.282190. PMID: 24247300; PMCID: PMC3934929.
https://jamanetwork.com/journals/jama/fullarticle/1779722 and FFPDF
Triposkiadis FK, Butler J, Karayannis G, Starling RC, Filippatos G, Wolski K, Parissis J, Parisis C, Rovithis D, Koutrakis K, Skoularigis J, Antoniou CK, Chrysohoou C, Pitsavos C, Stefanadis C, Nastas J, Tsaknakis T, Mantziari L, Giannakoulas G, Karvounis H, Kalogeropoulos AP, Giamouzis G. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial. Int J Cardiol. 2014 Mar 1;172(1):115-21. doi: 10.1016/j.ijcard.2013.12.276. Epub 2014 Jan 10. PMID: 24485633.
https://doi.org/10.1016/j.ijcard.2013.12.276
Schnuelle P, Gottmann U, Hoeger S, Boesebeck D, Lauchart W, Weiss C, Fischereder M, Jauch KW, Heemann U, Zeier M, Hugo C, Pisarski P, Krämer BK, Lopau K, Rahmel A, Benck U, Birck R, Yard BA. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA. 2009 Sep 9;302(10):1067-75. doi: 10.1001/jama.2009.1310. PMID: 19738091. FFD
Kotloff RM, Blosser S, Fulda GJ, Malinoski D, Ahya VN, Angel L, Byrnes MC, DeVita MA, Grissom TE, Halpern SD, Nakagawa TA, Stock PG, Sudan DL, Wood KE, Anillo SJ, Bleck TP, Eidbo EE, Fowler RA, Glazier AK, Gries C, Hasz R, Herr D, Khan A, Landsberg D, Lebovitz DJ, Levine DJ, Mathur M, Naik P, Niemann CU, Nunley DR, O’Connor KJ, Pelletier SJ, Rahman O, Ranjan D, Salim A, Sawyer RG, Shafer T, Sonneti D, Spiro P, Valapour M, Vikraman-Sushama D, Whelan TP; Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Donor Management Task Force. Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med. 2015 Jun;43(6):1291-325. doi: 10.1097/CCM.0000000000000958. PMID: 25978154.
https://doi.org/10.1097/ccm.0000000000000958
https://www.aacn.org/policy-and-advocacy/~/media/505419f7f56047708f76eef012a69c64.ashx
Juste RN, Moran L, Hooper J, Soni N. Dopamine clearance in critically ill patients. Intensive Care Med. 1998 Nov;24(11):1217-20. doi: 10.1007/s001340050747. PMID: 9876986.
https://doi.org/10.1007/s001340050747
Rui Q, Jiang Y, Chen M, Zhang N, Yang H, Zhou Y. Dopamine versus norepinephrine in the treatment of cardiogenic shock: A PRISMA-compliant meta-analysis. Medicine (Baltimore). 2017 Oct;96(43):e8402. doi: 10.1097/MD.0000000000008402. PMID: 29069037; PMCID: PMC5671870.
https://doi.org/10.1097/md.0000000000008402
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671870/pdf/medi-96-e8402.pdf
Goldberg LI. Dopamine–clinical uses of an endogenous catecholamine. N Engl J Med. 1974 Oct 3;291(14):707-10. doi: 10.1056/NEJM197410032911405. PMID: 4604342.
https://doi.org/10.1056/nejm197410032911405